Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Blood ; 125(7): 1180-8, 2015 Feb 12.
Article in English | MEDLINE | ID: mdl-25515962

ABSTRACT

Recently, we reported that distinct immunoglobulin (Ig) isotypes and IgG subclasses of factor VIII (FVIII)-specific antibodies are found in different cohorts of patients with hemophilia A and in healthy individuals. Prompted by these findings, we further investigated the distinguishing properties among the different populations of FVIII-specific antibodies. We hypothesized that the affinity of antibodies would discriminate between the neutralizing and nonneutralizing antibodies found in different study cohorts. To test this idea, we established a competition-based enzyme-linked immunosorbent assay technology to assess the apparent affinities for each isotype and IgG subclass of FVIII-specific antibodies without the need for antibody purification. We present a unique data set of apparent affinities of FVIII-specific antibodies found in healthy individuals, patients with congenital hemophilia A with and without FVIII inhibitors, and patients with acquired hemophilia A. Our data indicate that FVIII-specific antibodies found in patients with FVIII inhibitors have an up to 100-fold higher apparent affinity than that of antibodies found in patients without inhibitors and in healthy individuals. High-affinity FVIII-specific antibodies could be retrospectively detected in longitudinal samples of an individual patient with FVIII inhibitors 543 days before the first positive Bethesda assay. This finding suggests that these antibodies might serve as potential biomarkers for evolving FVIII inhibitor responses.


Subject(s)
Antibodies, Neutralizing/immunology , Antibody Affinity , Autoantibodies/immunology , Factor VIII/immunology , Hemophilia A/immunology , Adult , Aged , Aged, 80 and over , Case-Control Studies , Female , Hemophilia A/blood , Humans , Male , Middle Aged , Young Adult
2.
Blood ; 121(6): 1039-48, 2013 Feb 07.
Article in English | MEDLINE | ID: mdl-23243272

ABSTRACT

Neutralizing antibodies against factor VIII (FVIII) remain the major complication in the replacement therapy of hemophilia A patients. To better understand the evolution of these antibodies it is important to generate comprehensive datasets which include both neutralizing and nonneutralizing antibodies, their isotypes, and IgG subclasses. We developed sensitive ELISAs to analyze FVIII-binding antibodies in different cohorts of hemophilia A patients and in healthy individuals. Our data reveal the prevalence of FVIII-binding antibodies among healthy individuals (n = 600) to be as high as 19%, with a prevalence of antibody titers > or =1:80 of 2%. The prevalence of FVIII-binding antibodies was 34% (5% for titers > or =1:80) in patients without FVIII inhibitors (n = 77), 39% (4% for titers > 1:80) in patients after successful immune tolerance induction therapy (n = 23), and 100% (n = 20, all titers > or =1:80) in patients with FVIII inhibitors. We found significant differences for IgG subclasses of FVIII-binding antibodies between the different study cohorts. IgG4 and IgG1 were the most abundant IgG subclasses in patients with FVIII inhibitors. Strikingly, IgG4 was completely absent in patients without FVIII inhibitors and in healthy subjects. These findings point toward a distinct immune regulatory pathway responsible for the development of FVIII-specific IgG4 associated with FVIII inhibitors.


Subject(s)
Antibody Formation/immunology , Factor VIII/immunology , Hemophilia A/immunology , Immunoglobulin G/immunology , Adolescent , Adult , Aged , Antibodies, Neutralizing/blood , Antibodies, Neutralizing/immunology , Blood Coagulation Factor Inhibitors/therapeutic use , Cohort Studies , Enzyme-Linked Immunosorbent Assay , Factor VIII/antagonists & inhibitors , Female , Hemophilia A/blood , Hemophilia A/drug therapy , Humans , Immune Tolerance/drug effects , Immune Tolerance/immunology , Immunoglobulin G/blood , Immunoglobulin G/classification , Male , Middle Aged , Multivariate Analysis , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...